CD40 and cryptococcosis: Although not yet used in models of intestinal inflammation, polyICLC is protective in models of infections caused by influenza (220) or Dengue virus (221), murine cryptococcosis (222), and has been shown to enhance T cell responses in the lung of non-human primates when coadministered with anti-CD40 (223).